NASDAQ: CGTX - Cognition Therapeutics, Inc.

六个月盈利: -28.25%
股息率: 0.00%
部门: Healthcare

促销时间表 Cognition Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease.

更多详情
The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2021-10-08
ISIN US19243B1026
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.cogrx.com
Цена ао 0.495
每日价格变化: -0.7419% (0.4583)
每周价格变化: -22% (0.5832)
每月价格变化: -40.21% (0.7608)
3个月内价格变化: +13.16% (0.402)
六个月内的价格变化: -28.25% (0.634)
每年价格变化: -77.26% (2)
3年内价格变化: -84.47% (2.93)
5年内价格变化: 0% (0.4549)
10年价格变化: 0% (0.4549)
年初以来价格变化: -35.11% (0.701)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 2.16 7
P/E 0 0
EV/EBITDA -0.4577 0
全部的: 3.38

效率

姓名 意义 年级
ROA, % -73.34 0
ROE, % -105.37 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0034 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 628.83 10
盈利能力 EPS, % 163.99 10
全部的: 8
更多详情

机构 体积 分享, %
Pathstone Holdings, LLC 2205377 5.65
AIGH Capital Management LLC 2038853 5.23
Vanguard Group Inc 721554 1.85
Worth Venture Partners, LLC 508719 1.3
Carlson Capital. L.P. 238000 0.61
Kestra Advisory Services, LLC 219434 0.56
American Financial Group Inc. 205000 0.53
Geode Capital Management, LLC 174798 0.45
Mercer Global Advisors, Inc./ADV 130951 0.34
Commonwealth Equity Services, LLC 92730 0.24

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.00461 17.09 1.54048



导师 职称 支付 出生年份
Ms. Lisa Ricciardi CEO, President & Director 854.15k 1960 (65 年)
Dr. Anthony O. Caggiano M.D., Ph.D. Chief Medical Officer and Head of R&D 616.27k 1970 (55 年)
Mr. John Brendan Doyle Chief Financial Officer 414.88k 1977 (48 年)
Dr. Steven A. Weissman Ph.D. VP & Head of CMC N/A
Ms. Anita Cornet Head of Quality
Mr. Bobby Horn Corporate Controller

地址: United States, Purchase. NY, 2500 Westchester Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.cogrx.com